DOI QR코드

DOI QR Code

Stratifying Risk of Lymph Node Metastasis After Non-Curative Endoscopic Submucosal Dissection of Early Gastric Cancer: Comparison of the eCura System and Elderly Criteria

  • Tae-woo Kim (Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Hyo-Joon Yang (Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Giho Lee (Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Soo-Kyung Park (Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Yoon Suk Jung (Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jung Ho Park (Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Dong Il Park (Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Chong Il Sohn (Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
  • 투고 : 2024.09.29
  • 심사 : 2025.02.14
  • 발행 : 2025.04.01

초록

Purpose: The novel curability criteria for elderly (EL) patients have been proposed to stratify their risk of lymph node metastasis (LNM), following non-curative endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). Hence, this study aimed to evaluate the effectiveness of the EL criteria and compare them with those of the well-known eCura system. Materials and Methods: A retrospective analysis was performed on 143 patients who did not meet the curative ESD criteria at a tertiary hospital in Korea between 2011 and 2022. Of these, 102 underwent additional surgery, while 41 were followed up without further treatment. The LNM rates based on the EL and eCura systems were stratified and compared. Results: In the surgery group, 29.4% (30/102) patients were classified as EL-low (EL-L) and 70.2% (72/102) as EL-high (EL-H). The LNM rates (95% confidence interval) were 0.0% (0.0-11.6) and 9.7% (4.0-19.0) for EL-L and EL-H, respectively (P=0.102). EL-L was closely aligned with the eCura low-risk category, with a similar patient proportion (32.4%) and an LNM rate of 0.0% (0.0-10.6). The eCura system classified 94.1% (48/51) of the EL-L patients as low-risk, with an 86% concordance rate (123/143). Discordant cases included patients with positive vertical margins, but without other risk factors, who were classified as EL-H without LNM. Conclusions: Patients with EL-L showed no LNM, and the EL criteria demonstrated high concordance with the eCura system. The EL criteria may be as effective as the eCura system in identifying low-risk patients after non-curative ESD for EGC.

키워드

과제정보

This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (grant number: 2020R1G1A1010927).

참고문헌

  1. Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer 2023;23:3-106. https://doi.org/10.5230/jgc.2023.23.e11
  2. Park CH, Yang DH, Kim JW, Kim JH, Kim JH, Min YW, et al. Clinical practice guideline for endoscopic resection of early gastrointestinal cancer. Clin Endosc 2020;53:142-166. https://doi.org/10.5946/ce.2020.032
  3. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer 2023;26:1-25. https://doi.org/10.1007/s10120-022-01331-8
  4. Ono H, Yao K, Fujishiro M, Oda I, Uedo N, Nimura S, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc 2021;33:4-20. https://doi.org/10.1111/den.13883
  5. Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2022. Endoscopy 2022;54:591-622. https://doi.org/10.1055/a-1811-7025
  6. Forbes N, Elhanafi SE, Al-Haddad MA, Thosani NC, Draganov PV, Othman MO, et al. American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations. Gastrointest Endosc 2023;98:271-284. https://doi.org/10.1016/j.gie.2023.03.015
  7. Yang HJ, Kim SG, Lim JH, Choi J, Im JP, Kim JS, et al. Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer. Surg Endosc 2015;29:1145-1155. https://doi.org/10.1007/s00464-014-3780-7
  8. Kim ER, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ, et al. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer. Br J Surg 2015;102:1394-1401. https://doi.org/10.1002/bjs.9873
  9. Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, et al. Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan. J Gastroenterol 2017;52:175-184. https://doi.org/10.1007/s00535-016-1210-4
  10. Suzuki H, Oda I, Abe S, Sekiguchi M, Nonaka S, Yoshinaga S, et al. Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series. Gastric Cancer 2017;20:679-689. https://doi.org/10.1007/s10120-016-0651-z
  11. Kawata N, Kakushima N, Takizawa K, Tanaka M, Makuuchi R, Tokunaga M, et al. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection. Surg Endosc 2017;31:1607-1616. https://doi.org/10.1007/s00464-016-5148-7
  12. Jung DH, Huh CW, Kim JH, Hong JH, Park JC, Lee YC, et al. Risk-stratification model based on lymph node metastasis after noncurative endoscopic resection for early gastric cancer. Ann Surg Oncol 2017;24:1643-1649. https://doi.org/10.1245/s10434-017-5791-9
  13. Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, et al. A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: "eCura system". Am J Gastroenterol 2017;112:874-881. https://doi.org/10.1038/ajg.2017.95
  14. Sekiguchi M, Oda I, Taniguchi H, Suzuki H, Morita S, Fukagawa T, et al. Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer. J Gastroenterol 2016;51:961-970. https://doi.org/10.1007/s00535-016-1180-6
  15. Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, et al. Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study. Gastric Cancer 2018;21:481-489. https://doi.org/10.1007/s10120-017-0769-7
  16. Yang HJ, Kim YI, Ahn JY, Choi KD, Kim SG, Jeon SW, et al. External validation of the eCura system for undifferentiated-type early gastric cancer with noncurative endoscopic resection. Gut Liver 2023;17:537-546. https://doi.org/10.5009/gnl220333
  17. Yang HJ, Lee H, Kim TJ, Jung DH, Choi KD, Ahn JY, et al. A modified eCura system to stratify the risk of lymph node metastasis in undifferentiated-type early gastric cancer after endoscopic resection. J Gastric Cancer 2024;24:172-184. https://doi.org/10.5230/jgc.2024.24.e13
  18. Morais R, Libanio D, Dinis Ribeiro M, Ferreira A, Barreiro P, Bourke MJ, et al. Predicting residual neoplasia after a non-curative gastric ESD: validation and modification of the eCura system in the Western setting: the W-eCura score. Gut 2023;73:105-117. https://doi.org/10.1136/gutjnl-2023-330804
  19. Sekiguchi M, Suzuki H, Takizawa K, Hirasawa T, Takeuchi Y, Ishido K, et al. Potential for expanding indications and curability criteria of endoscopic resection for early gastric cancer in elderly patients: results from a Japanese multicenter prospective cohort study. Gastrointest Endosc 2024;100:438-448.e1. https://doi.org/10.1016/j.gie.2024.01.026
  20. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112. https://doi.org/10.1007/s10120-011-0041-5
  21. Nakamura Y, Yasuoka H, Tsujimoto M, Kurozumi K, Nakahara M, Nakao K, et al. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer. J Clin Pathol 2006;59:77-82. https://doi.org/10.1136/jcp.2005.028779
  22. Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer 2009;12:148-152. https://doi.org/10.1007/s10120-009-0515-x
  23. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000;3:219-225. https://doi.org/10.1007/PL00011720
  24. Kim YI, Kook MC, Choi JE, Lee JY, Kim CG, Eom BW, et al. Evaluation of submucosal or lymphovascular invasion detection rates in early gastric cancer based on pathology section interval. J Gastric Cancer 2020;20:165-175. https://doi.org/10.5230/jgc.2020.20.e14
  25. Furukawa K, Kamiya S, Sugino T, Aizawa D, Kawabata T, Notsu A, et al. Optimal extent of lymph node dissection in patients with gastric cancer who underwent non-curative endoscopic submucosal dissection with a positive vertical margin. Eur J Surg Oncol 2020;46:2229-2235. https://doi.org/10.1016/j.ejso.2020.07.002
  26. Hayasaka J, Kikuchi D, Nomura K, Odagiri H, Ochiai Y, Suzuki Y, et al. Recurrence rate of intramucosal gastric cancer with positive vertical margin due to lesion damage during endoscopic submucosal dissection. Acta Gastroenterol Belg 2021;84:289-294. https://doi.org/10.51821/84.2.289
  27. Park YS, Kook MC, Kim BH, Lee HS, Kang DW, Gu MJ, et al. A standardized pathology report for gastric cancer: 2nd edition. J Gastric Cancer 2023;23:107-145. https://doi.org/10.5230/jgc.2023.23.e7